Formaldehyde Found in GMO Soybeans
R
esearchers from the International Center for Integrative Systems, in Cambridge, Massachu-
setts, have determined that genetically modi- fied (GM/GMO) soybean plants accumulate the carcinogen formaldehyde. The researchers utilized a scientific
method called CytoSolve to analyze 6,497 diverse laboratory studies conducted by 184 scientific institutions in 23 countries worldwide. The study data showed that GMO soybeans significantly ac- cumulate formaldehyde, a class-one carcinogen.
The research also found that genetic modification forces a deple- tion of glutathione among the plants, which weakens their immune system. This contrasts with the proposals put forth by the GM indus- try that GMO soybean plants are stronger, allowing them to endure environmental hardships better than non-GMO soybean plants. The research was led by V.A. Shiva Ayyadurai, Ph.D., a bi-
ologist trained at the Massachusetts Institute of Technology, and published in the peer-reviewed journal Agricultural Sciences. “The results demand immediate testing, along with rigorous scientific standards to assure such testing is objective and replicable. It’s un- believable such standards for testing don’t already exist. The safety of our food supply demands that science delivers such modern scientific standards for approval of GMOs,” states Ayyadurai. Former Environmental Protection Agency Senior Scientist Ray
Seidler, Ph.D., comments about the study, “The discovery reported by Ayyadurai reveals a new molecular paradigm associated with genetic engineering that will require research to discover why the extent of formaldehyde and glutathione concentrations are altered, and what other chemicals relevant to human and animal health are affected. We need the kinds of standards Ayyadurai demands to conduct such research.”
Antidepressants in Pregnancy Raises Risk of Hypertension in Kids
I
n a large study published in the Journal of the American Medical Association, research- ers from participating universi- ties found mothers that take antidepressant drugs during pregnancy face the risk of heart issues for their children. The researchers tested 3,789,330 pregnant women
between 2000 and 2010. Of these, 128,950 took at least one prescription for antidepressants during their pregnancy. High blood pressure among children of mothers that didn’t take antidepressants was about 21 percent. Children that were exposed to selective se- rotonin reuptake inhibitor (SSRI) antidepressant drugs during pregnancy experienced high blood pressure in 31.5 percent of the cases. Those that were exposed to non-SSRI antidepressants experienced high blood pres- sure 29 percent of the time. This represents a 50 percent increased risk of hyper- tension for babies of mothers that take SSRIs during pregnancy and a 40 percent increased risk for children exposed to non-SSRIs.
In their conclusion, the researchers note, “Evidence from publicly insured pregnant women studied may be consistent with a potential increased risk of persistent pulmonary hypertension of the newborn associated with maternal use of selective serotonin reuptake inhibitors in late pregnancy.”
natural awakenings November 2015
19
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64